Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06515366

MAP( Mean Arterial Pressure) and Mortality Relation in Patients With Heart Failure

Evaluation of the Relationship Between Mean Arterial Pressure (MAP) and Mortality in Patients With Heart Failure: A Perspective From Emergency Department Monitoring and Hospital Presentation

Status
Recruiting
Phase
Study type
Observational
Enrollment
280 (estimated)
Sponsor
Saglik Bilimleri Universitesi · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Aim of this observational study is to evaluate the relationship between mean arterial pressure (MAP) and mortality in patients presenting to the emergency department with acute heart failure, focusing on emergency department monitoring and subgroup presentations. Our goal is to determine the impact of subgroup characteristics on mortality among patients presenting with heart failure in the emergency department, and to assess the predictive value and significance of MAP in predicting mortality.

Detailed description

After obtaining ethical approval, the study will commence within 2 weeks and continue for 1 year. Based on clinical statistics or general literature data, and considering sample size calculations, a total of 280 patients across 4 groups have been determined. Inclusion Criteria: Age 18 and above Patients presenting with symptoms of heart failure Exclusion Criteria: Age under 18 Patients presenting with ST-elevation myocardial infarction Patients with acute kidney failure Pregnant patients Patients with inaccessible data for the parameters under study Groups based on initial mean arterial pressure (MAP) upon hospital admission will be established as follows: \<65 mmHg, 66-80 mmHg, 81-100 mmHg, \>100 mmHg. Data including results of emergency department tests and pertinent findings will be recorded for patients in these groups. The 30-day mortality rates of these patients will be statistically evaluated based on their MAP values and the procedures performed during emergency department monitoring.

Conditions

Timeline

Start date
2024-06-01
Primary completion
2025-06-01
Completion
2025-06-01
First posted
2024-07-23
Last updated
2024-07-23

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06515366. Inclusion in this directory is not an endorsement.